Answer
In vitro, approximately 65% of irinotecan and 95% of its active metabolite SN-38 bind to plasma proteins.
Sources for this answer
- Campto 20mg/ml concentrate for solution for infusion (40mg presentation)Pfizer Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 27Document updated
Sources checked